glomerulonephritis
Showing 26 - 50 of 759
Idiopathic Membranous Nephropathy
Not yet recruiting
- Idiopathic Membranous Nephropathy
- Obinutuzumab Injection
- (no location specified)
May 8, 2023
Immunoglobulin A Nephropathy, Kidney Diseases, Glomerulonephritis, IGA Trial in Leicester (Sparsentan)
Recruiting
- Immunoglobulin A Nephropathy
- +5 more
-
Leicester, United KingdomLeicester General Hospital, University Hospitals of Leicester NH
May 18, 2022
C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Worldwide (Danicopan)
Terminated
- C3 Glomerulonephritis
- +4 more
-
Birmingham, Alabama
- +12 more
Aug 9, 2022
C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Ranica (Non
Completed
- C3 Glomerulonephritis
- +4 more
- Non contrast-enhanced magnetic resonance imaging
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Dac
Nov 24, 2021
Hyperspectral Imaging Technique in CTX Treatment of IMN
Not yet recruiting
- Hyperspectral Imaging
- +2 more
- Microscopic hyperspectral imaging system
- (no location specified)
Apr 29, 2023
Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)
Not yet recruiting
- Primary Membranous Nephropathy
- (no location specified)
May 16, 2023
C3 Glomerulopathy, C3 Glomerulonephritis, Dense Deposit Disease Trial in United Kingdom, United States (Danicopan, Placebo)
Prognostic Model of TAC in the Treatment of MN
Not yet recruiting
- Idiopathic Membranous Nephropathy
- (no location specified)
Dec 28, 2022
IgA Nephropathy, Immunoglobulin A Nephropathy Trial (BION-1301, Placebo)
Not yet recruiting
- IgA Nephropathy
- Immunoglobulin A Nephropathy
- BION-1301
- Placebo
- (no location specified)
May 2, 2023
IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)
Active, not recruiting
- IgA Nephropathy (IgAN)
- +2 more
- Placebo
- Cemdisiran
-
Vancouver, British Columbia, Canada
- +19 more
Jan 13, 2023
US Time-Harmonic Elastography for Early Detection of Childhood
Active, not recruiting
- Glomerulonephritis
-
Assiut, EgyptAssiut University
Jul 19, 2021
IgA Nephropathy Trial (CM338)
Not yet recruiting
- IgA Nephropathy
- CM338
- (no location specified)
Mar 7, 2023
Hyperspectral Imaging Technique in the Treatment of IMN by TAC
Not yet recruiting
- Idiopathic Membranous Nephropathy
- +2 more
- Tacrolimus for the treatment of IMN
- (no location specified)
Mar 31, 2023
Prognostic Model of GC/CTX in the Treatment of MN
Not yet recruiting
- Idiopathic Membranous Nephropathy
- glucocorticoid + cytoxan
- (no location specified)
Dec 28, 2022
Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)
Not yet recruiting
- Idiopathic Membranous Nephropathy
- glucocorticoid + tacrolimus
- (no location specified)
Dec 28, 2022
T- and B-Cell Subpopulations in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- +2 more
-
Istanbul, TurkeyIstanbul University
May 31, 2023
Kidney Diseases, Kidney Failure, Chronic, Diabetic Nephropathy Trial in New York
Recruiting
- Kidney Diseases
- +4 more
-
New York, New YorkThe Rogosin Institute
Feb 28, 2022
Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)
Not yet recruiting
- Membranous Nephropathy
- Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
-
Nice, FranceCHU de NICE
Jul 4, 2023
Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)
Not yet recruiting
- Primary IgA Nephropathy
- SHR-2010 Injection
- Placebo
- (no location specified)
Apr 27, 2023
Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)
Recruiting
- Idiopathic Membranous Nephropathy
- Rituximab
- Modified Ponticelli regimen
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 23, 2023